REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study

Figures & data

Table 1 Wilcoxon Signed-Rank Test Results

NPPO Modality of Treatment Administration (N = 150)
SIGN TEST
	Depression post – Depression pre	Anxiety post – Anxiety pre	Stress post – Stress pre
Z	−10.417	−10.083	−11.161
Asymp. Sig. (2-tailed)	0.000	0.000	0.000
WILCOXON
	Depression post – Depression pre	Anxiety post – Anxiety pre	Stress post – Stress pre
Z	−10.021	−9.482	−10.133
Asymp. Sig. (2-tailed)	0.000	0.000	0.000
NPPO-CB MODALITY OF TREATMENT ADMINISTRATION (N = 150)
SIGN TEST
	Depression post – Depression pre	Anxiety post – Anxiety pre	Stress post – Stress pre
Z	−10.780	−10.676	−11.007
Asymp. Sig. (2-tailed)	0.000	0.000	0.000
WILCOXON
	Depression post – Depression pre	Anxiety post – Anxiety pre	Stress post – Stress pre
Z	−9.848	−9.873	−10.097
Asymp. Sig. (2-tailed)	0.000	0.000	0.000

Abbreviations: DASS 21, Depression Anxiety Stress Scale; NPO, neuro postural optimization; NPPO, neuro psycho physical optimization; NPPO-CB, neuro psycho physical optimization-cervico brachial; ACP, asymmetric conveyer probe.

Figure 1 NPPO modality of treatment administration: efficacy in the reduction of the symptoms in the three clusters, from T0 to T3.

Figure 2 NPPO-CB modality of treatment administration: efficacy in the reduction of the symptoms in the three clusters, from T0 to T3.

Figure 3 NPPO modality of treatment administration: comparison between T0 and T3 in the three clusters.

Figure 4 NPPO-CB modality of treatment administration: comparison between T0 and T3 in the three clusters.

Figure 5 Effectiveness comparison across groups. Results at T0 and T3 compared across NPPO and NPPO-CB treatment modalities in each cluster.